SCHEMBL21067338

SCHEMBL21067338

CC(=O)Nc1cnn(-c2ccc(F)cc2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.52
KDM1A O60341 1/20 0.51
MAOA P21397 1/20 0.51
MAOB P27338 1/20 0.51
KMT2A Q03164 4/20 0.47
MEN1 O00255 2/20 0.47
POLB P06746 1/20 0.47
MAPK8 P45983 2/20 0.47
MAPK10 P53779 2/20 0.47
ITGB1 P05556 1/20 0.46
ITGA2 P17301 1/20 0.46
ATM Q13315 1/20 0.44
EGFR P00533 1/20 0.42
FGFR1 P11362 1/20 0.42
KDR P35968 1/20 0.42
LMNA P02545 2/20 0.41
GAA P10253 1/20 0.41
OGT O15294 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4281610 0.84 EGFR (0.54) NAMPTMAPK8MAPK10EGFRFGFR1
SCHEMBL28655500 0.81 NTRK1 (0.50) KDM1AMAOAMAOBITGB1ITGA2
SCHEMBL15813925 0.79 NAMPT (0.43) NAMPTKDM1AMAOAMAOBKMT2A
SCHEMBL20729411 0.78 KCNH3 (0.41) NAMPTKDM1AMAOAMAOBMAPK8
SCHEMBL24720685 0.77 OGT (0.44) NAMPTKDM1AMAOAMAOBKMT2A
SCHEMBL4966121 0.77 HPGD (0.45) NAMPTKMT2APOLBMAPK8MAPK10
SCHEMBL23507791 0.76 KDM1A (0.44) NAMPTKDM1AMAOAMAOBKMT2A
SCHEMBL15815784 0.75 NAMPT (0.43) NAMPTKDM1AMAOAMAOBPOLB
SCHEMBL7807810 0.74 NAMPT (0.70) NAMPTKDM1AMAOAMAOBKMT2A
SCHEMBL22831669 0.74 MAPT (0.45) KMT2AMEN1GAAOGTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed